Relyea Zuckerberg Hanson’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,816
Closed -$244K 310
2026
Q1
$244K Buy
2,816
+96
+4% +$9.2K 0.02% 239
2025
Q4
$261K Sell
2,720
-96
-3% -$9.32K 0.03% 223
2025
Q3
$268K Buy
2,816
+50
+2% +$4.6K 0.03% 229
2025
Q2
$241K Sell
2,766
-1,248
-31% -$106K 0.03% 236
2025
Q1
$361K Buy
4,014
+890
+28% +$79.6K 0.05% 186
2024
Q4
$250K Buy
3,124
+372
+14% +$32.2K 0.03% 234
2024
Q3
$248K Buy
+2,752
New +$232K 0.04% 218
2024
Q2
Sell
-2,381
Closed -$208K 243
2024
Q1
$208K Buy
+2,381
New +$203K 0.04% 222
2023
Q4
Sell
-3,389
Closed -$266K 235
2023
Q3
$266K Buy
3,389
+401
+13% +$33.6K 0.06% 157
2023
Q2
$263K Buy
2,988
+207
+7% +$17.8K 0.06% 163
2023
Q1
$224K Buy
+2,781
New +$227K 0.05% 170

Other funds holding MDT

Relyea Zuckerberg Hanson's MDT Position: Q2 2026 in Review

Relyea Zuckerberg Hanson sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,816 shares — an estimated $244K sold.

Relyea Zuckerberg Hanson first reported a position in MDT in Q1 2023 and held it in 11 quarters. The position peaked at $361K in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Relyea Zuckerberg Hanson reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Relyea Zuckerberg Hanson sold 2,816 Medtronic shares in Q2 2026, an estimated $244K.
  • Relyea Zuckerberg Hanson first reported a position in Medtronic in Q1 2023 and held it in 11 quarters.
  • Relyea Zuckerberg Hanson's Medtronic position peaked at $361K in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.